Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: Two-year results - VIP report #4.

被引：0
作者：
Lim, JI [1 ]
机构：
[1] Univ So Calif, Doheny Eye Inst, VIP Study Grp, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2001年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1637
引用
收藏
页码：S304 / S304
页数：1
相关论文
共 50 条
[21]   Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: Comparison with nontreated controls [J].
Hayashi, Kengo ;
Ohno-Matsui, Kyoko ;
Teramukai, Satoshi ;
Shimada, Noriaki ;
Moriyama, Muka ;
Hara, Wakako ;
Yoshida, Takeshi ;
Tokoro, Takashi ;
Mochizuki, Manabu .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (03) :518-526
[22]   Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin - Fluorescein angiographic guidelines for evaluation and treatment - TAP and VIP report no. 2 [J].
Barbazetto, I ;
Burdan, A ;
Bressler, NM ;
Bressler, SB ;
Haynes, L ;
Kapetanios, AD ;
Lukas, J ;
Olsen, K ;
Potter, M ;
Reaves, A ;
Rosenfeld, P ;
Schachat, AP ;
Strong, HA ;
Wenkstern, A ;
Burdan, M ;
Reaves, D .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (09) :1253-1268
[23]   Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia [J].
M. Rinaldi ;
F. Semeraro ;
F. Chiosi ;
A. Russo ;
M. R. Romano ;
M. C. Savastano ;
R. dell’Omo ;
C. Costagliola .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 :529-539
[24]   Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia [J].
Rinaldi, M. ;
Semeraro, F. ;
Chiosi, F. ;
Russo, A. ;
Romano, M. R. ;
Savastano, M. C. ;
dell'Omo, R. ;
Costagliola, C. .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) :529-539
[25]   Verteporfin photodynamic therapy (PDT) for extrafoveal and juxtafoveal choroidal neovascularization (CNV) in pathologic myopia: A long term follow-up study [J].
Herrmann, A .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 :U671-U671
[26]   Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia [J].
Francesco Bandello ;
Paolo Lanzetta ;
Maurizio Battaglia Parodi ;
Derri Roman-Pognuz ;
Sandro Saviano ;
Giuseppe Ravalico .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2003, 241 :567-570
[27]   Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia [J].
Bandello, F ;
Lanzatta, P ;
Parodi, MB ;
Roman-Pognuz, D ;
Saviano, S ;
Ravalico, G .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 241 (07) :567-570
[28]   Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial [J].
Kaiser, Peter K. .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) :1853-1860
[29]   Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia - Results from a randomized pilot study [J].
Costa, Rogerio A. ;
Williams, George A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (07) :757-764
[30]   A comparison study of photodynamic therapy using Veteporfin for choroidal neovascularization (CNV) subfoveal in patients [J].
Celis, B .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 :U132-U132
12345